RDHL Earnings

RDHL reported its earnings on 2025-09-05, showcasing a revenue of 4.08M against an estimate of , resulting in a 0% surprise. The EPS was 0, surpassing the expected 0 by 0%. The stock experienced a 16.54% price change on the earnings day and a 22.76% change over the next five days, reflecting market reactions to the results.

Following RDHL's earnings announcement on 2025-09-05, the stock price moved by 16.54% on the day of the release. Over the subsequent five days, it saw a 22.76% change. Historically, RDHL's stock price tends to shift by an average of 12.18% in the 10 days leading up to earnings and 3.32% in the 10 days following, providing insight into potential market.

For 2023/Q3, analysts estimate RDHL's annual revenue to reach 24.17M, while the EPS is projected at -10.00. These estimates reflect recent revisions, with revenue estimates revised downward by -21.86% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between RDHL's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for were revised downward by -21.86%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, RDHL's stock price typically moves by 12.18% in the 10 days before its earnings and 3.32% in the 10 days after. For the upcoming 2023/Q3 earnings, analysts expect an EPS of -10.00 and revenue of 24.17M.

The earnings call reveals concerns about regulatory challenges, reliance on external funding, and decreased net revenues. Despite operational cost savings and reduced cash usage, the biotech sector's downturn and competitive pressures from a new FDA-approved drug pose risks. The Q&A highlights management's lack of clarity on strategic moves and uncertainties around COVID-19 therapeutics. These factors suggest a negative sentiment, likely leading to a stock price decline over the next two weeks.